RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Urticaria Therapy Area Pipeline Report
Nov 2010 - 118 pages - $1,495
Chronic Urticaria Or Hives - Pipeline Review, Q4 2010
Dec 2010 - 25 pages - $500
Chronic Urticaria Or Hives - Pipeline Review, Q2 2011
Apr 2011 - 38 pages - $500
Chronic Urticaria Or Hives - Pipeline Review, H2 2011
Aug 2011 - 42 pages - $500
Biofrontera AG (B8F) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 38 pages - $250
Chronic Urticaria or Hives Global Clinical Trials Review, Q1, 2011
Mar 2011 - 61 pages - $1,000
Biofrontera AG - Product Pipeline Review - Q4 2010
Nov 2010 - 41 pages - $500
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
Oct 2011 - 89 pages - $3,500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Dermatological del
Urticaria del
Development phase
Phase III/IV del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us